Byhealth Co., Ltd (SHE:300146)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Dietary Supplement Business	6.27B	6.84B	9.41B	7.86B	7.43B
Dietary Supplement Business Growth	-8.38%	-27.30%	19.66%	5.79%	21.93%
Total	6.27B	6.84B	9.41B	7.86B	7.43B
Total Growth	-8.38%	-27.30%	19.66%	5.79%	21.93%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Australia	1.00B	872.28M	989.03M	805.40M	664.34M
Australia Growth	14.97%	-11.80%	22.80%	21.23%	16.22%
China	5.08B	5.73B	7.94B	6.71B	6.62B
China Growth	-11.42%	-27.76%	18.24%	1.38%	20.10%
Hong Kong and Others	321.03M	337.58M	550.94M	407.48M	315.21M
Hong Kong and Others Growth	-4.90%	-38.73%	35.21%	29.27%	351.68%
Inter-Segment Elimination	-137.61M	-105.51M	-70.87M	-64.42M	-169.68M
Total	6.27B	6.84B	9.41B	7.86B	7.43B
Total Growth	-8.38%	-27.30%	19.66%	5.79%	21.93%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error